Department of Neurology

Faculty - Lawrence W. Elmer, M.D., Ph.D.

Lawrence Elmer MD PhDProfessor of Neurology
Director, The Center for Neurological Health

SPECIAL INTERESTS

Parkinson's Disease
Essential Tremor
Huntington's Disease
Tourette's Syndrome
Parkinson's Plus Syndromes
Stiff-Person Syndrome
Dystonias
Molecular basis of neurodegeneration
Neuronal mitochondrial dysfunction and apoptosis

EDUCATION

M.D.: University of Florida, Gainesville, Florida, 1982-1987
Ph.D: University of Florida College of Medicine, Gainesville, Florida, 1982-1988
Medicine Residency: Sioux Falls V.A. Medical Center, Sioux Falls, South Dakota, 1988-1989
Neurology Residency: University of Michigan, Ann Arbor, Michigan, 1989-1992
Fellowship: Research Associate, Howard Hughes Medical Institute, University of Michigan, 1992-1994

PROFESSIONAL APPOINTMENTS

Lecturer in Movement Disorders: University of Michigan, 1992-1994
Research Scientist: Ann Arbor VA Medical Center, 1994-1998
Assistant Professor: University of Michigan, 1994-1998
Assistant Professor: Medical University of Ohio, 1998-2009
Professor: University of Toledo (formerly Medical University of Ohio, 2009-present

CERTIFICATIONS

American Board of Psychiatry and Neurology, 1994

SOCIETY MEMBERSHIPS

American Academy of Neurology
New York Academy of Science
Society for Neuroscience

AWARDS and Honors

Dean's Award for Teaching Excellence, 2003
Golden Apple Teaching Award, 2003-2007, 2010, 2011, 2014
Awarded Humanism in Medicine - MUO, Class of 2003, 2002, 2015
Named in list of America's Best Doctors, 2001-2012, 2015, 2016, 2017
Teaching Scholar, Medical University of Ohio, 2000-01
Pfizer Scholar 1995-97

EDITORIAL

Ad hoc reviewer
Journal of Clinical Investigation, 1997
Neurology Network Commentary, 1997

SELECTED PUBLICATIONS

Hauser RA, Kremens DE, Elmer LW, Kreitzman DL, Walsh RR, Johnson R, Howard R, Nguyen JT, Patni R. Prevalence of Dyskinesia and OFF by 30-Minute Intervals Through the Day and Assessment of Daily Episodes of Dyskinesia and OFF: Novel Analyses of Diary Data from Gocovri Pivotal Trials. J Parkinsons Dis. 2019;9(3):591-600. doi: 10.3233/JPD-181565. PMID: 31081793; PMCID: PMC6700613

Hauser RA, Kremens DE, Elmer LW, Kreitzman DL, Walsh RR, Johnson R, Howard R, Nguyen JT, Patni R. Prevalence of Dyskinesia and OFF by 30-Minute Intervals Through the Day and Assessment of Daily Episodes of Dyskinesia and OFF: Novel Analyses of Diary Data from Gocovri Pivotal Trials. J Parkinsons Dis. 2019;9(3):591-600.

Nicholas AP, Borgohain R, Chaná P, Surmann E, Thompson EL, Bauer L, Whitesides J, Elmer LW. A Randomized Study of Rotigotine Dose Response on 'Off' Time in Advanced Parkinson's Disease. J Parkinsons Dis. 2014 Mar 18.

Elmer LW, Surmann E, Boroojerdi B, Jankovic J. Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: A prospective, open-label extension study.  Parkinsonism Relat Disord. 2012 Jun;18(5):488-93.

Abbas J, Nazzal M, Serrano P, Elmer L. Aortic arch abnormality in a patient with Klippel-Feil syndrome. Vascular. 2006 Jan-Feb;14(1):43-6.

Elmer L, Schwid S, Eberly S, Goetz C, Fahn S, Kieburtz K, Oakes D, Blindauer K, Salzman P, Oren S, Prisco UL, Stern M, Shoulson I; Parkinson Study Group TEMPO and PRESTO Investigators.   Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms.  J Neurol Sci. 2006 Oct 25;248(1-2):78-83. Epub 2006 Jul 7.

Last Updated: 7/15/24